Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.

Time-in-range outcomes from a recent clinical study of a novel tubeless AID system revealed:
a. -10% to +9.8% across all age (14-50+ yoa) groups
b. -2.3%% to +11.2% across all age groups
c. +9.5% to +9.8% across all age groups
d. +8.0% to +13% across all age groups

Submit is supported by independent educational grants from Ascensia Diabetes Care, Insulet Corporation and Medtronic.
©2022 CogniMed Inc. All rights reserved.